109 related articles for article (PubMed ID: 38430689)
1. Exploring the molecular and immune-landscape of lung cancer associated with cystic airspaces.
Zheng X; Qiu L; Huang Y; Cheng R; Huang S; Xu K; Cai W; Deng Y; Wang W; Zhong X; Cui F; Hao Z; Liu J
Mol Immunol; 2024 Apr; 168():75-88. PubMed ID: 38430689
[TBL] [Abstract][Full Text] [Related]
2. Prognosis of lung cancer associated with cystic airspaces: A propensity score matching analysis.
Shen Y; Zhang Y; Guo Y; Li W; Huang Y; Wu T; Jiang G; Dai J
Lung Cancer; 2021 Sep; 159():111-116. PubMed ID: 34325317
[TBL] [Abstract][Full Text] [Related]
3. Prognostic impact of lymphovascular invasion compared with that of visceral pleural invasion in patients with pN0 non-small-cell lung cancer and a tumor diameter of 2 cm or smaller.
Tao H; Hayashi T; Sano F; Takahagi A; Tanaka T; Matsuda E; Okabe K
J Surg Res; 2013 Nov; 185(1):250-4. PubMed ID: 23830361
[TBL] [Abstract][Full Text] [Related]
4. Prognostic value of visceral pleural invasion in the stage pT
Zhang X; Xie J; Hu S; Peng W; Xu B; Li Y; Li C
Curr Probl Cancer; 2021 Feb; 45(1):100640. PubMed ID: 32828574
[TBL] [Abstract][Full Text] [Related]
5. Proposal on incorporating lymphovascular invasion as a T-descriptor for stage I lung cancer.
Wang S; Zhang B; Qian J; Qiao R; Xu J; Zhang L; Zhao Y; Zhang Y; Wang R; Zhao R; Han B
Lung Cancer; 2018 Nov; 125():245-252. PubMed ID: 30429028
[TBL] [Abstract][Full Text] [Related]
6. Prognostic impact and initial recurrence site of lymphovascular and visceral pleural invasion in surgically resected stage I non-small-cell lung carcinoma.
Yanagawa N; Shiono S; Abiko M; Ogata SY; Sato T; Tamura G
Eur J Cardiothorac Surg; 2013 Sep; 44(3):e200-6. PubMed ID: 23766428
[TBL] [Abstract][Full Text] [Related]
7. Prognostic Impact of Multiple Clinicopathologic Risk Factors and c-MET Overexpression in Patients Who Have Undergone Resection of Stage IB Non-Small-Cell Lung Cancer.
Kim IH; Lee IH; Lee JE; Hong SH; Kim TJ; Lee KY; Kim YK; Kim SJ; Sung SW; Park JK; Yoo IR; Kim YS; Kim JO; Kang JH
Clin Lung Cancer; 2016 Sep; 17(5):e31-e43. PubMed ID: 26992846
[TBL] [Abstract][Full Text] [Related]
8. [Prognostic study of visceral pleural invasion by pulmonary adenocarcinoma with tumor size ≤3 cm].
Chen TY; Ma HW; Jin RR; Xu C; Hua HJ; Song GX; Zhang WM; Zhang ZH
Zhonghua Bing Li Xue Za Zhi; 2017 Aug; 46(8):553-558. PubMed ID: 28810296
[No Abstract] [Full Text] [Related]
9. Re-evaluation of the prognostic value of visceral pleura invasion in Stage IB non-small cell lung cancer using the prospective multicenter ACOSOG Z0030 trial data set.
Fibla JJ; Cassivi SD; Brunelli A; Decker PA; Allen MS; Darling GE; Landreneau RJ; Putnam JB
Lung Cancer; 2012 Dec; 78(3):259-62. PubMed ID: 23040416
[TBL] [Abstract][Full Text] [Related]
10. Lung cancers associated with cystic airspaces: CT features and pathologic correlation.
Shen Y; Xu X; Zhang Y; Li W; Dai J; Jiang S; Wu T; Cai H; Sihoe A; Shi J; Jiang G
Lung Cancer; 2019 Sep; 135():110-115. PubMed ID: 31446982
[TBL] [Abstract][Full Text] [Related]
11. Identification and Validation of a Tumor Microenvironment-Related Gene Signature for Prognostic Prediction in Advanced-Stage Non-Small-Cell Lung Cancer.
Zhang X; Shi X; Zhao H; Jia X; Yang Y
Biomed Res Int; 2021; 2021():8864436. PubMed ID: 33860055
[TBL] [Abstract][Full Text] [Related]
12. Effects of adjuvant chemotherapy on survival of patients with stage IB non-small cell lung cancer with visceral pleural invasion.
Xie J; Zhang X; Hu S; Peng WD; Xu B; Li Y; Zhang SJ; Li Q; Li C
J Cancer Res Clin Oncol; 2020 Sep; 146(9):2231-2239. PubMed ID: 32533405
[TBL] [Abstract][Full Text] [Related]
13. Visceral pleura invasion by non-small cell lung cancer: an underrated bad prognostic factor.
Manac'h D; Riquet M; Medioni J; Le Pimpec-Barthes F; Dujon A; Danel C
Ann Thorac Surg; 2001 Apr; 71(4):1088-93. PubMed ID: 11308141
[TBL] [Abstract][Full Text] [Related]
14. [Progress in Diagnosis and Treatment of Lung Cancer Associated with Cystic Airspaces].
Yang J; Chen Y; Lei Y; Huang Y
Zhongguo Fei Ai Za Zhi; 2023 Oct; 26(10):774-781. PubMed ID: 37989340
[TBL] [Abstract][Full Text] [Related]
15. A risk classification system predicting the cancer-specific survival for postoperative stage IB non-small-cell lung cancer patients without lymphovascular and visceral pleural invasion.
Tu Z; Li C; Tian T; Chen Q
Lung Cancer; 2021 Nov; 161():114-121. PubMed ID: 34583219
[TBL] [Abstract][Full Text] [Related]
16. Prognostic impact of microscopic vessel invasion and visceral pleural invasion in non-small cell lung cancer: a retrospective analysis of 2657 patients.
Neri S; Yoshida J; Ishii G; Matsumura Y; Aokage K; Hishida T; Nagai K
Ann Surg; 2014 Aug; 260(2):383-8. PubMed ID: 24646539
[TBL] [Abstract][Full Text] [Related]
17. Bioinformatic analysis revealing mitotic spindle assembly regulated NDC80 and MAD2L1 as prognostic biomarkers in non-small cell lung cancer development.
Wei R; Wang Z; Zhang Y; Wang B; Shen N; E L; Li X; Shang L; Shang Y; Yan W; Zhang X; Ma W; Wang C
BMC Med Genomics; 2020 Aug; 13(1):112. PubMed ID: 32795325
[TBL] [Abstract][Full Text] [Related]
18. [Impact of visceral pleural invasion on the prognosis of stage Ib non-small cell lung cancer].
Su XD; Long H; Wang X; Fu JH; He JH; Lin P; Zhang LJ; Ma GW
Zhonghua Zhong Liu Za Zhi; 2008 May; 30(5):368-71. PubMed ID: 18953838
[TBL] [Abstract][Full Text] [Related]
19. Immune Infiltration in Tumor and Adjacent Non-Neoplastic Regions Codetermines Patient Clinical Outcomes in Early-Stage Lung Cancer.
Cheng C; Nguyen TT; Tang M; Wang X; Jiang C; Liu Y; Gorlov I; Gorlova O; Iafrate J; Lanuti M; Christiani DC; Amos CI
J Thorac Oncol; 2023 Sep; 18(9):1184-1198. PubMed ID: 37146750
[TBL] [Abstract][Full Text] [Related]
20. Prognostic characterization of immune molecular subtypes in non-small cell lung cancer to immunotherapy.
Li C; Pan J; Luo J; Chen X
BMC Pulm Med; 2021 Nov; 21(1):389. PubMed ID: 34844602
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]